Generation of a Biologically Active, Secreted Form of Human Thyroid Peroxidase by Site-Directed Mutagenesis
- 1 May 1990
- journal article
- research article
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 4 (5) , 786-791
- https://doi.org/10.1210/mend-4-5-786
Abstract
Using site-directed mutagenesis, we introduced two stop codons immediately upstream of the putative transmembrane domain in human thyroid peroxidase (hTPO) cDNA, truncating the carboxyl terminus of hTPO (933 amino acids) by 85 residues. Mutated hTPO cDNA, inserted into a eukaryotic expression vector, was stably transfected into Chinese hamster ovary (CHO) cells. Immunoprecipitation of cellular 35S-methionine-labeled proteins with Hashimoto''s serum revealed a 105-101 kilodalton doublet. In contrast, cells transfected with wild-type hTPO yielded a 112-105 kilodalton doublet. In pulse-chase experiments, CHO cells expressing the truncated hTPO protein secreted immunoprecipitable TPO into the culture medium after 4 h of chase, with levels accumulating progressively over a 24-h period. In contrast, CHO cells expressing wild-type hTPO released no immunoprecipitable TPO into the culture medium. The secreted, truncated form of hTPO appeared as a single band of lesser electrophoretic mobility, as opposed to the doublet expressed within cells. TPO enzymatic activity was present in conditioned media from CHO cells transfected with the mutated in hTPO, but was absent in media from cells expressing wild-type hTPO. The stability of the mutated protein appeared similar to that of wild-type hTPO. In summary, we have generated a mutated, secreted from of hTPO that is enzymatically active and immunologically intact. Our data confirm the existence of a transmembrane domain in hTPO, and that hTPO is predominantly an enzyme with an extracellular orientation. The secreted form of hTPO has the potential for generating large amounts of soluble TPO protein for use in future structural and immunological studies.This publication has 23 references indexed in Scilit:
- Characterization of Human Thyroid Peroxidase Purified by Monoclonal Antibody-Assisted Chromatography*Journal of Clinical Endocrinology & Metabolism, 1986
- Replacement of insulin receptor tyrosine residues 1162 and 1163 compromises insulin-stimulated kinase activity and uptake of 2-deoxyglucoseCell, 1986
- Detection of Autoantibodies to Thyroid Peroxidase in Autoimmune Thyroid Diseases by Micro-ELISA and Immunoblotting*Journal of Clinical Endocrinology & Metabolism, 1986
- ANTI-THYROID PEROXIDASE ANTIBODY IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE: POSSIBLE IDENTITY WITH ANTI-MICROSOMAL ANTIBODYJournal of Clinical Endocrinology & Metabolism, 1985
- PRESENCE OF THE ORGAN-SPECIFIC MICROSOMAL AUTO-ANTIGEN ON THE SURFACE OF HUMAN THYROID-CELLS IN CULTURE - ITS INVOLVEMENT IN COMPLEMENT-MEDIATED CYTO-TOXICITY1981
- DNA sequencing with chain-terminating inhibitorsProceedings of the National Academy of Sciences, 1977
- Purification of Bovine Thyroid Peroxidase*Endocrinology, 1977
- Biosynthesis of thyroid hormone: Basic and clinical aspectsMetabolism, 1977
- Site of Iodination in the Rat Thyroid Gland Deduced from Electron Microscopic AutoradiographsEndocrinology, 1975
- Metabolism of125I in the Thyroid Gland Studied with Electron Microscopic AutoradiographyEndocrinology, 1964